Skip to main content

Advertisement

Log in

Acute Lymphoblastic Leukemia in the Course of Polycythemia Vera: A Case Report and Review of Literature

  • Case Report
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

Introduction

Polycythemia vera (PV) is one of the most common forms of myeloproliferative neoplasms. Acute myeloid leukemia secondary to PV is well reported, and the mechanism has been clarified to some extent. Only a limited number of cases have been reported about the development of acute lymphoblastic leukemia (ALL) in the course of PV, and the possible underlying mechanism has not been explored well.

Case presentation

A 75-year-old patient who developed ALL 3 years after he was diagnosed with PV. The presence of remarkable splenomegaly, typical immunophenotyping of the peripheral blood and increased expression of serum fibrosis markers indicated the existence of extramedullary hematopoiesis which may ascribe to myelofibrosis. After the treatment of dosage-modulated chemotherapy, the patient got complete remission.

Conclusion

The JAK2 mutation may the underlying factor that contributes to the development of ALL, and the existence of MF may indicate the progression to post- polycythemic MF, which may be a risk factor for the accelerated transformation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Anastasi J (2009) The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis. Hematol Oncol Clin N Am 23(4):693–708

    Article  Google Scholar 

  2. Najean Y, Rain JD (1997) Treatment of polycythemia vera: the use of hydroxyurea and pipobroman in 292 patients under the age of 65 years. Blood 90(9):3370–3377

    CAS  PubMed  Google Scholar 

  3. Rampal R, Mascarenhas J (2014) Pathogenesis and management of acute myeloid leukemia that has evolved from a myeloproliferative neoplasm. Curr Opin Hematol 21(2):65–71

    Article  CAS  PubMed  Google Scholar 

  4. Camós M, Cervantes F, Montoto S, Hernández-Boluda JC, Villamor N, Montserrat E (1999) Acute lymphoid leukemia following polycythemia vera. Leuk Lymphoma 32(3–4):395–398

    Article  PubMed  Google Scholar 

  5. Rege-Cambrin G, Mecucci C, Tricot G, Michaux JL, Louwagie A, Van Hove W, Francart H, Van den Berghe H (1987) A chromosomal profile of polycythemia vera. Cancer Genet Cytogenet 25(2):233–245

    Article  CAS  PubMed  Google Scholar 

  6. Roth AD, Oral A, Przepiorka D, Gollin SM, Chervenick PA (1993) Chronic myelogenous leukemia and acute lymphoblastic leukemia occurring in the course of polycythemia vera. Am J Hematol 43(2):123–128

    Article  CAS  PubMed  Google Scholar 

  7. Neilson JR, Patton WN, Williams MD, Mayne EE, Boughton BJ (1994) Polycythaemia rubra vera transforming to acute lymphoblastic leukaemia with a common immunophenotype. J Clin Pathol 47(5):471–472

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Anastasi J, Pettenati MJ, Le Beau MM, Kwaan HC, Weil SC (1988) Acute lymphoblastic leukemia in a patient with longstanding polycythemia vera: cytogenetic analysis reveals two distinct abnormal clones. Am J Hematol 29(1):33–37

    Article  CAS  PubMed  Google Scholar 

  9. Tefferi A, Vardiman JW (2008) Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 22(1):14–22

    Article  CAS  PubMed  Google Scholar 

  10. Lee HJ, Daver N, Kantarjian HM, Verstovsek S, Ravandi F (2013) The role of JAK pathway dysregulation in the pathogenesis and treatment of acute myeloid leukemia. Clin Cancer Res 19(2):327–335

    Article  CAS  PubMed  Google Scholar 

  11. Xu W, Chen B, Tong X (2014) Chronic myeloid leukemia patient with co-occurrence of BCR-ABL junction and JAK2 V617F mutation. Int J Hematol 99(1):87–90

    Article  PubMed  Google Scholar 

  12. Ohyashiki K, Aota Y, Akahane D, Gotoh A, Miyazawa K, Kimura Y, Ohyashiki JH (2005) The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients. Leukemia 19(12):2359–2360

    Article  CAS  PubMed  Google Scholar 

  13. Yang YN, Qin YW, Wang C (2014) JAK2 V617F detected in two B-cell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosome-negative myeloproliferative neoplasms: a report of two cases. Oncol Lett. 8(2):841–844

    CAS  PubMed  PubMed Central  Google Scholar 

  14. dos Santos NR, Ghysdael J (2006) A transgenic mouse model for TEL-JAK2-induced B-cell lymphoma/leukemia. Leukemia 20(1):182–185

    Article  PubMed  Google Scholar 

  15. Papageorgiou MV, Alexopoulou A, Kontopidou F, Filiotou A, Koskinas J, Pectasides D (2011) Concomitant diagnosis of myeloproliferative neoplasm and non-Hodgkin’s lymphoma in a patient with portal vein thrombosis. Anticancer Res 31(4):1467–1469

    PubMed  Google Scholar 

  16. Malhotra J, Kremyanskaya M, Schorr E, Hoffman R, Mascarenhas J (2014) Coexistence of myeloproliferative neoplasm and plasma-cell dyscrasia. Clin Lymphoma Myeloma Leuk 14(1):31–36

    Article  PubMed  Google Scholar 

  17. Elli EM, Belotti A, Cecchetti C, Realini S, Fedele M, Parma M, Pogliani EM (2013) Development of JAK2V617F-positive polycythemia vera after chemotherapy-induced remission of primary central nervous system diffuse large B cell non-Hodgkin’s lymphoma: a case report and review of the literature. Acta Haematol 130(3):142–145

    Article  CAS  PubMed  Google Scholar 

  18. Sutherland ND, Gonzalez-Peralta R, Douglas-Nikitin V, Hunger SP (2004) Polycythemia vera in a child following treatment for acute lymphoblastic leukemia. J Pediatr Hematol Oncol 26(5):315–319

    Article  PubMed  Google Scholar 

  19. Hann HW, Festa RS, Rosenstock JG, Cifuentes E (1979) Polycythemia vera in a child with acute lymphocytic leukemia. Cancer 43(5):1862–1865

    Article  CAS  PubMed  Google Scholar 

  20. Danish EH, Rasch CA, Harris JW (1980) Polycythemia vera in childhood: case report and review of the literature. Am J Hematol 9(4):421–428

    Article  CAS  PubMed  Google Scholar 

  21. Najfeld V, Cozza A, Berkofsy-Fessler W, Prchal J, Scalise A (2007) Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V > F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms. Exp Hematol 35(11):1668–1676

    Article  CAS  PubMed  Google Scholar 

  22. Yu W, Chen L, Li J, Zhu H (2014) Essential thrombocythemia with JAK2 V617F mutation transformed into acute myeloid leukemia without JAK2 V617F mutation: case report and literature review. Zhonghua Xue Ye Xue Za Zhi. 35(12):1122–1123

    CAS  PubMed  Google Scholar 

  23. Ohanian M, Leventaki V, Verstovsek S, Estrov Z, Lin P, Yin C, Kantarjian H, Huh Y, Ravandi F (2012) Acute lymphoblastic leukemia arising in post-polycythemic myelofibrosis: a rare entity. Leuk Lymphoma 53(9):1839–1841

    Article  PubMed  PubMed Central  Google Scholar 

  24. Polliack A, Prokocimer M, Matzner Y (1980) Lymphoblastic leukemic transformation (lymphoblastic crisis) in myelofibrosis and myeloid metaplasia. Am J Hematol 9(2):211–220

    Article  CAS  PubMed  Google Scholar 

  25. Tefferi A, Lasho TL, Jimma T, Finke CM, Gangat N, Vaidya R, Begna KH, Al-Kali A, Ketterling RP, Hanson CA, Pardanani A (2012) One thousand patients with primary myelofibrosis: the mayo clinic experience. Mayo Clin Proc 87(1):25–33

    Article  PubMed  PubMed Central  Google Scholar 

  26. Mesa RA, Li CY, Ketterling RP, Schroeder GS, Knudson RA, Tefferi A (2005) Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases. Blood 105(3):973–977

    Article  CAS  PubMed  Google Scholar 

  27. Arrago JP, Poirier O, Chomienne C, D’Agay MF, Najean Y (1986) Type III aminoterminal propeptide of procollagen in some haematological malignancies. Scand J Haematol 36(3):288–294

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Baodong Ye.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, D., Ye, B., Shen, J. et al. Acute Lymphoblastic Leukemia in the Course of Polycythemia Vera: A Case Report and Review of Literature. Indian J Hematol Blood Transfus 32 (Suppl 1), 50–55 (2016). https://doi.org/10.1007/s12288-015-0598-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-015-0598-y

Keywords

Navigation